Today news
About the same in other media
Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
Reading now: 703
economictimes.indiatimes.comOrchid Pharma, the Chennai-based drug maker on Tuesday said it has entered into a technology transfer agreement with a leading multinational biotechnology company for its fermentation based ‘7ACA project’ under the production linked incentive (PLI) scheme. The company didn't disclose the name of the biotechnology firm or further details of the agreement.
Orchid Pharma announced that its wholly-owned subsidiary, Orchid Bio Pharma, has received approval to manufacture ‘7-ACA’ with a capacity of 1,000 tonne per annum. 7-ACA (7-aminocephalosporanic acid) is a key intermediate for the synthesis of semisynthetic cephalosporin antibiotics.
Read more on economictimes.indiatimes.comAbout this in other media
Top 20 Best Hair Transplant Clinics in Turkey, Istanbul livemint.com /1 year ago
US Senator Menendez says he has not changed opposition to Turkey F-16 sale investing.com /1 year ago
Binance Blockchain Week picks Turkey to host thousands of Web3 lovers cointelegraph.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
